Evidence map›Paper›PMID 27387434›Full record

ArticleBMC medical informatics and decision making2016

Development and validation of the Italian version of the Mobile Application Rating Scale and its generalisability to apps targeting primary prevention.

Alexander Domnich, Lucia Arata, Daniela Amicizia, Alessio Signori, Bernard Patrick, Stoyan Stoyanov, Leanne Hides, Roberto Gasparini, Donatella Panatto

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Criteria for assessing the quality of mHealth apps: a systematic review.Journal of the American Medical Informatics Association : JAMIA · 2018
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Validity and reliability assessment of the Persian version of the User Mobile Application Rating Scale.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alexander DomnichDepartment of Health Sciences, University of Genoa, Genoa, Italy. alexander.domnich@gmail.com.
Lucia ArataDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Daniela AmiciziaDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Alessio SignoriDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Bernard PatrickSchool of Medical and Pharmaceutical Sciences, University of Genoa, Genoa, Italy.
Stoyan StoyanovInstitute of Health & Biomedical Innovation, School of Psychology and Counselling, Queensland University of Technology, Brisbane, Australia.
Leanne HidesInstitute of Health & Biomedical Innovation, School of Psychology and Counselling, Queensland University of Technology, Brisbane, Australia.
Roberto GaspariniDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Donatella PanattoDepartment of Health Sciences, University of Genoa, Genoa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA growing body of literature affirms the usefulness of mobile technologies, including mobile applications (apps), in the primary prevention field. The quality of health apps, which today number in the thousands, is a crucial parameter, as it may affect health-related decision-making and outcomes among app end-users. The mobile application rating scale (MARS) has recently been developed to evaluate the quality of such apps, and has shown good psychometric properties. Since there is no standardised tool for assessing the apps available in Italian app stores, the present study developed and validated an Italian version of MARS in apps targeting primary prevention.

methodsThe original 23-item version of the MARS assesses mobile app quality in four objective quality dimensions (engagement, functionality, aesthetics, information) and one subjective dimension. Validation of this tool involved several steps; the universalist approach to achieving equivalence was adopted. Following two backward translations, a reconciled Italian version of MARS was produced and compared with the original scale. On the basis of sample size estimation, 48 apps from three major app stores were downloaded; the first 5 were used for piloting, while the remaining 43 were used in the main study in order to assess the psychometric properties of the scale. The apps were assessed by two raters, each working independently. The psychometric properties of the final version of the scale was assessed including the inter-rater reliability, internal consistency, convergent, divergent and concurrent validities.

resultsThe intralingual equivalence of the Italian version of the MARS was confirmed by the authors of the original scale. A total of 43 apps targeting primary prevention were tested. The MARS displayed acceptable psychometric properties. The MARS total score showed an excellent level of both inter-rater agreement (intra-class correlation coefficient of .96) and internal consistency (Cronbach's α of .90 and .91 for the two raters, respectively). Other types of validity, including convergent, divergent, discriminative, known-groups and scalability, were also established.

conclusionsThe Italian version of MARS is a valid and reliable tool for assessing the health-related primary prevention apps available in Italian app stores.

Indexed as

Primary PreventionHumansItalyMobile ApplicationsPsychometricsReproducibility of ResultsSurveys and QuestionnairesTelemedicinemHealthMobile applicationMobile application rating scaleMobile healthPrevention

Identifiers

PMID27387434
PMCPMC4936279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.